Literature DB >> 27006985

A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice.

Emily Reeve, Danijela Gnjidic, Janet Long, Sarah Hilmer.   

Abstract

AIMS: The aim of this study was to identify what definitions have been published for the term 'deprescribing', and determine whether a unifying definition could be reached. A secondary aim was to uncover patterns between the published definitions which could explain any variation.
METHODS: Systematic literature searches were performed (earliest records to February 2014) in MEDLINE, Embase, CINAHL, Informit, Scopus and Google Scholar. The terms deprescrib* or de-prescrib* were employed as a keyword search in all fields. Conventional content analysis and word frequencies were used to identify characteristics of the definitions. Network analysis was conducted to visualize characteristic distribution across authors and articles.
RESULTS: Following removal of duplicates, 231 articles were retrieved, 37 of which included a definition. Eight characteristics of the definitions were identified: use of the term stop/withdraw/cease/discontinue (35 articles), aspect of prescribing included e.g. long term therapy/inappropriate medications (n = 18), use of the term 'process' or 'structured' (n = 13), withdrawal is planned/supervised/judicious (n = 11), involving multiple steps (n = 7), includes dose reduction/substitution (n = 7), desired goals/outcomes described (n = 5) and involves tapering (n = 4). Network analysis did not reveal patterns responsible for variations in previously used definitions.
CONCLUSIONS: These findings show that there is lack of consensus on the definition of deprescribing. This article proposes the following definition: 'Deprescribing is the process of withdrawal of an inappropriate medication, supervised by a health care professional with the goal of managing polypharmacy and improving outcomes'. This definition has not yet been externally validated and further work is required to develop an internationally accepted and appropriate definition.

Mesh:

Year:  2015        PMID: 27006985      PMCID: PMC4693477          DOI: 10.1111/bcp.12732

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  46 in total

Review 1.  Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes.

Authors:  Danijela Gnjidic; David G Le Couteur; Lisa Kouladjian; Sarah N Hilmer
Journal:  Clin Geriatr Med       Date:  2012-02-21       Impact factor: 3.076

Review 2.  Comparison of published explicit criteria for potentially inappropriate medications in older adults.

Authors:  Chirn-Bin Chang; Ding-Cheng Chan
Journal:  Drugs Aging       Date:  2010-12-01       Impact factor: 3.923

3.  People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to Deprescribe.

Authors:  Emily Reeve; Michael D Wiese; Ivanka Hendrix; Michael S Roberts; Sepehr Shakib
Journal:  J Am Geriatr Soc       Date:  2013-08-26       Impact factor: 5.562

4.  Deprescribing: what is it and what does the evidence tell us?

Authors:  Wade Thompson; Barbara Farrell
Journal:  Can J Hosp Pharm       Date:  2013-05

5.  Dementia - an update on management.

Authors:  Dimity Pond
Journal:  Aust Fam Physician       Date:  2012-12

Review 6.  Managing medications in clinically complex elders: "There's got to be a happy medium".

Authors:  Michael A Steinman; Joseph T Hanlon
Journal:  JAMA       Date:  2010-10-13       Impact factor: 56.272

7.  Quality use of medicines and health outcomes among a cohort of community dwelling older men: an observational study.

Authors:  Christopher Beer; Zoë Hyde; Osvaldo P Almeida; Paul Norman; Graeme J Hankey; Bu B Yeap; Leon Flicker
Journal:  Br J Clin Pharmacol       Date:  2011-04       Impact factor: 4.335

Review 8.  Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches.

Authors:  Julian Lindsay; Michael Dooley; Jennifer Martin; Michael Fay; Alison Kearney; Michael Barras
Journal:  Support Care Cancer       Date:  2013-12-21       Impact factor: 3.603

9.  Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process.

Authors:  Kevin T Bain; Holly M Holmes; Mark H Beers; Vittorio Maio; Steven M Handler; Stephen G Pauker
Journal:  J Am Geriatr Soc       Date:  2008-09-02       Impact factor: 5.562

Review 10.  Medication withdrawal trials in people aged 65 years and older: a systematic review.

Authors:  Shoba Iyer; Vasi Naganathan; Andrew J McLachlan; David G Le Couteur
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

View more
  140 in total

1.  Effect of Clinical Geriatric Assessments and Collaborative Medication Reviews by Geriatrician and Family Physician for Improving Health-Related Quality of Life in Home-Dwelling Older Patients Receiving Polypharmacy: A Cluster Randomized Clinical Trial.

Authors:  Rita Romskaug; Eva Skovlund; Jørund Straand; Espen Molden; Hege Kersten; Kaisu H Pitkala; Christofer Lundqvist; Torgeir B Wyller
Journal:  JAMA Intern Med       Date:  2020-02-01       Impact factor: 21.873

Review 2.  Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients.

Authors:  Brendan J Ng; David G Le Couteur; Sarah N Hilmer
Journal:  Drugs Aging       Date:  2018-06       Impact factor: 3.923

Review 3.  Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis.

Authors:  Tim Johansson; Muna E Abuzahra; Sophie Keller; Eva Mann; Barbara Faller; Christina Sommerauer; Jennifer Höck; Christin Löffler; Anna Köchling; Jochen Schuler; Maria Flamm; Andreas Sönnichsen
Journal:  Br J Clin Pharmacol       Date:  2016-05-07       Impact factor: 4.335

Review 4.  Why maximum tolerated dose?

Authors:  Hans G Stampfer; Genevieve M Gabb; Simon B Dimmitt
Journal:  Br J Clin Pharmacol       Date:  2019-07-22       Impact factor: 4.335

Review 5.  Guidance for appropriate use of psychotropic drugs in older people.

Authors:  Andreas Capiau; Katrien Foubert; Annemie Somers; Mirko Petrovic
Journal:  Eur Geriatr Med       Date:  2021-01-08       Impact factor: 1.710

6.  Tapering or abrupt cessation of proton pump inhibitors?

Authors:  Emily Reeve; Sarah Hilmer
Journal:  Eur J Clin Pharmacol       Date:  2017-03-22       Impact factor: 2.953

Review 7.  Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults.

Authors:  Tom D Wilsdon; Ivanka Hendrix; Tilenka R J Thynne; Arduino A Mangoni
Journal:  Drugs Aging       Date:  2017-04       Impact factor: 3.923

8.  Older Patient and Caregiver Perspectives on Medication Value and Deprescribing: A Qualitative Study.

Authors:  Aimee N Pickering; Megan E Hamm; Alicia Dawdani; Joseph T Hanlon; Carolyn T Thorpe; Walid F Gellad; Thomas R Radomski
Journal:  J Am Geriatr Soc       Date:  2020-02-17       Impact factor: 5.562

9.  Effectiveness of an intervention to optimise the use of mirabegron for overactive bladder: a quasi-experimental study in primary care.

Authors:  Eladio Fernández-Liz; Pere Vivó Tristante; Antonio Aranzana Martínez; Maria Estrella Barceló Colomer; Josep Ossó Rebull; Maria Josep López Dolcet
Journal:  Br J Gen Pract       Date:  2018-11-19       Impact factor: 5.386

10.  Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy.

Authors:  Alessandro Galazzi; Maura Lusignani; Maria Teresa Chiarelli; Pier Mannuccio Mannucci; Carlotta Franchi; Mauro Tettamanti; Emily Reeve; Alessandro Nobili
Journal:  Int J Clin Pharm       Date:  2016-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.